If the same type of facility works for almost every kind of vaccine, do we think there would be interest in constructing the facilities as a speculative venture? Consider:
1. The economy is in chaos and may remain so, which I expect to produce unusually affordable access to design firms, construction crews, raw materials, and land.
2. There will be a strong incentive for regulators/​inspectors to move with best speed, and the current administration at least in the US has a track record of being friendly to shortcuts.
3. If the facilities are already built, this allows a limit to the risk the companies producing the vaccines need to absorb in order to increase supply.
4. We could squeeze out unscrupulous opportunists.
If the same type of facility works for almost every kind of vaccine, do we think there would be interest in constructing the facilities as a speculative venture? Consider:
1. The economy is in chaos and may remain so, which I expect to produce unusually affordable access to design firms, construction crews, raw materials, and land.
2. There will be a strong incentive for regulators/​inspectors to move with best speed, and the current administration at least in the US has a track record of being friendly to shortcuts.
3. If the facilities are already built, this allows a limit to the risk the companies producing the vaccines need to absorb in order to increase supply.
4. We could squeeze out unscrupulous opportunists.